Successful antimanic treatment and mood stabilization with lamotrigine, clozapine, and valproate in a bipolar patient after lithium-induced cerebellar deterioration. A case report.
Dembowski
C
C
Department of Psychiatry and Psychotherapy, District Hospital Rendsburg, Germany.
Rechlin
T
T
D000927:Anticonvulsants / Q000627:therapeutic use*; D018692:Antimanic Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001259:Ataxia / Q000139:chemically induced*; D001714:Bipolar Disorder / Q000188:drug therapy*; D003024:Clozapine / Q000627:therapeutic use*; D003680:Deglutition Disorders / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D004401:Dysarthria / Q000139:chemically induced*; D006801:Humans; D000077213:Lamotrigine; D008094:Lithium / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D019964:Mood Disorders / Q000188:drug therapy*; D014227:Triazines / Q000627:therapeutic use*; D014635:Valproic Acid / Q000627:therapeutic use*
D000927:Anticonvulsants; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D014227:Triazines; D014635:Valproic Acid; D008094:Lithium; D003024:Clozapine; D000077213:Lamotrigine